Human Fractalkine Recombinant Protein LyophilizedIHUFCTKRLY5UG
Human Fractalkine Recombinant Protein Lyophilized from Innovative Research has been recombinantly produced in E. coli. This is a Lyophilized protein buffered in with a purity of Greater than 98% by SDS-PAGE gel and HPLC analyses.
Endotoxin level is less than 0.1 ng per and#956;g (1EU/and#956;g)..
- Species: Human
- Target: CX3CL1
Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.
Endotoxin level is less than 0.1 ng per and#956;g (1EU/and#956;g).
- Source: E. coli
- Storage Conditions: The lyophilized Fractalkine recombinant protein is stable for at least 2 years from date of receipt at -20°C. Reconstituted Fractalkine is stable for at least 3 months when stored in working aliquots with a carrier protein at -20°C. As with any protein, exposing Fractalkine recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.
Human Fractalkine is a member of the newly discovered CX3C family of chemokines which contains both chemokine and mucin domain. Human Fractalkine is an 8.5 kDa protein containing 76 amino acid residues and comprises only the chemokine domain of Fractalkine.
. At Innovative Research we provide reliable, consistent products that deliver reliable, consistent results.
This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Get in touch with our team! Please include any relevant information (product name, etc)